Frown lines, also known as the vertical lines between the eyebrows, are commonly treated with neurotoxins. Neurotoxins, such as Botox, Dysport, and Xeomin, are especially effective for this area. In fact, this is the only region currently FDA-approved for all BoNTA neurotoxins.
Understanding the anatomy behind frown lines is crucial for effective treatment.
The vertical lines of the glabella are caused by the contraction of the paired corrugator supercilii muscles, while the horizontal lines are due to the centrally located procerus muscle.
Despite the seemingly straightforward anatomy, there are subtle variations that can be observed during facial movement.
There are two distinct patterns of corrugator positioning: either straight along the brow or more vertically oriented in a V-shape.
Because of these variations, injectors should not rely on a single technique. Instead, they should visualize the underlying muscles and their impact on wrinkle formation during facial animation.
Injecting in this area requires careful attention to minimize risks. One potential side effect is upper lid ptosis, which can appear up to 2 weeks after the injection and may last for 2 to 4 weeks. To reduce this risk, ensure injections are placed 1 cm above the superior orbital rim.
While there is no clinical data indicating that post-treatment instructions can decrease ptosis or improve results, some physicians provide the following guidelines to their patients as a precaution:
To minimize the risk of bruising and maximize the effectiveness of the treatment, consider the following post-injection instructions:
Diffusion into Eyelid: Product diffusion into the eyelid can affect the levator palpebrae superioris muscle, possibly leading to transient ptosis (drooping eyelid).
Here are some tips for effective injection technique: